Loading company…
Medcura is a Maryland medical device company developing hemostatic and wound treatment products, including its LifeGel surgical gel.
Founded in 2013 and based in Maryland, US, Medcura Inc. develops hemostatic and wound treatment products using biopolymer technology. Its flagship product, LifeGel, controls surgical bleeding and is aimed at spine, cardiac and minimally invasive procedures. The company raised USD 22.4 million in venture debt funding in March 2024, and Jim Buck is its President, CEO and Director as of August 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in